|
Hepalink Announces Exciting Regulatory Developments
|
12
|
Resverlogix Corp.
|
Jun 29, 2020 06:11AM
|
|
Re: Next private placement/licensing agreement
|
12
|
Resverlogix Corp.
|
Feb 07, 2019 09:46AM
|
|
Re: Not out of the woods yet with COVID-19
|
11
|
Resverlogix Corp.
|
Feb 18, 2022 03:04PM
|
|
Re: BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
|
11
|
Resverlogix Corp.
|
Apr 27, 2020 12:56PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
9
|
Resverlogix Corp.
|
Apr 05, 2022 12:51PM
|
|
Re: December 22, 2020.wideout
|
8
|
Resverlogix Corp.
|
Oct 10, 2020 03:35PM
|
|
Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
8
|
Resverlogix Corp.
|
Feb 17, 2022 07:19AM
|
|
April 28 - 29 | Exclusive Digital Event-Triple Negative Breast Cancer
|
8
|
Zenith Epigenetics
|
Feb 12, 2021 07:07AM
|
|
Re: Veru vs Resverlogix
|
8
|
Resverlogix Corp.
|
Apr 17, 2022 07:08AM
|
|
Re: A bit of DD.
|
8
|
Resverlogix Corp.
|
Dec 10, 2021 03:55PM
|
|
Re: Where's the kool aid gang?
|
8
|
Resverlogix Corp.
|
May 21, 2022 01:23PM
|
|
Re: a new study that one researcher called "stunning."
|
8
|
Resverlogix Corp.
|
Feb 11, 2022 09:18AM
|
|
Re: Cummings
|
8
|
Resverlogix Corp.
|
Dec 04, 2019 08:17AM
|
|
Re: We have received a violation report regarding your post and have found it in violation of our policy.???
|
8
|
Resverlogix Corp.
|
Jan 31, 2020 06:19PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
8
|
Resverlogix Corp.
|
Jun 22, 2020 10:43AM
|
|
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19
|
7
|
Resverlogix Corp.
|
Oct 12, 2021 04:46PM
|
|
Re: Forward looking statements...
|
7
|
Resverlogix Corp.
|
Feb 05, 2021 09:10AM
|
|
Re: Kausik Ray tweeted this this morning
|
7
|
Resverlogix Corp.
|
Aug 18, 2022 07:37AM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
7
|
Resverlogix Corp.
|
Oct 26, 2020 02:04PM
|
|
Re: BRD2 involvement in Covid19
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 10:06PM
|
